Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Total
July 2022 Public Offering
Previously Reported
Preferred Stock
Series A preferred stock
Preferred Stock
Series A-1 preferred stock
Preferred Stock
Previously Reported
Series A preferred stock
Preferred Stock
Previously Reported
Series A-1 preferred stock
Common Stock
Common Stock
July 2022 Public Offering
Common Stock
Previously Reported
Additional Paid-in Capital
Additional Paid-in Capital
July 2022 Public Offering
Additional Paid-in Capital
Previously Reported
Accumulated Deficit
Accumulated Deficit
Previously Reported
Retrospective application of reverse recapitalization       $ (3,903,730) $ (3,578,197)     $ 206     $ 7,481,721        
Retrospective application of reverse recapitalization, Shares       (628,930) (684,450)     205,658              
Reverse stock split fractionAL stock round up               $ 10     (10)        
Reverse stock split fractionAL stock round up, Shares               10,412              
Balance at Dec. 31, 2020 $ 3,411,624   $ 3,411,624 $ (3,499,997) $ (3,578,197) $ 403,733   $ 282   $ 66 13,019,998   $ 5,538,287 $ (2,530,462) $ (2,530,462)
Balance (in Shares) at Dec. 31, 2020         (684,450) 628,930   281,589   65,519          
Issuance of common stock 99,998                   99,998        
Issuance of common stock (Shares)               450              
Issuance of Revelation Sub Series A-1 Preferred Stock, net 3,904,872       $ 3,904,872                    
Issuance of Revelation Sub Series A-1 Preferred Stock, net (Shares)         684,450                    
Issuance of Warrants in connection with the issuance of the Revelation Sub Series A-1 Preferred Stock         $ (326,675)           326,675        
Payment for Series A Preferred Stock subscribed       3,499,997                      
Payment for Revelation Sub Series A Preferred Stock subscribed 3,499,997                            
Payment for common stock subscribed 499,998                   499,998        
Stock-based compensation expense 470,878                   470,878        
Net loss (11,986,837)                         (11,986,837)  
Balance at Dec. 31, 2021 (99,470)   $ (99,470)     $ 3,903,730 $ 3,578,197 $ 282   $ 66 14,417,547   $ 6,935,836 (14,517,299) $ (14,517,299)
Balance (in Shares) at Dec. 31, 2021           628,930 684,450 282,039   65,969          
Retrospective application of reverse recapitalization       $ (3,903,730) $ (3,578,197)     $ 206     7,481,721        
Retrospective application of reverse recapitalization, Shares       (628,930) (684,450)     205,658              
Reverse stock split fractionAL stock round up               $ 10     (10)        
Reverse stock split fractionAL stock round up, Shares               10,412              
Issuance of common stock   $ 4,451,048             $ 238     $ 4,450,810      
Issuance of common stock (Shares)                 238,096            
Issuance of common stock in connection with the Business Combination, net 6,864,327             $ 98     6,864,229        
Issuance of common stock in connection with the Business Combination, net (in shares)               98,209              
Issuance of common stock for fees in connection with the Business Combination 300             $ 9     291        
Issuance of common stock for fees in connection with the Business Combination (Shares)               8,572              
Proceeds from the PIPE Investment, net 7,262,219             $ 37     7,262,182        
Proceeds from the PIPE Investment, net (in Shares)               36,947              
Rollover Warrant Exercise 5,074                   5,074        
Rollover Warrant Exercise (in Shares)               54              
Repurchase for the Forward Share Purchase Agreement exercise (7,652,325)             $ (21)     (7,652,304)        
Repurchase for the Forward Share Purchase Agreement exercise (in Shares)               (21,429)              
Pre-Funded Warrants Exercise 13             $ 37     (24)        
Pre-Funded Warrants Exercise (in Shares)               36,959              
RSU awards issued               $ 3     (3)        
RSU awards issued, Shares               3,435              
Issuance of common stock for Accrued Expenses in connection with the Business Combination 749,700                   749,700        
Issuance of Series A Preferred Stock, Shares       1                      
Stock-based compensation expense 301,116                   301,116        
Net loss (10,829,549)                         (10,829,549)  
Balance at Dec. 31, 2022 $ 1,052,453             $ 683     $ 26,398,618     $ (25,346,848)  
Balance (in Shares) at Dec. 31, 2022       1       682,882